Market Analysis and Price Projections for NDC: 62559-0601 (Inderal XL)
Overview of Inderal XL
Inderal XL, with the NDC code 62559-0601, is a medication manufactured by ANI Pharmaceuticals, Inc. It is a long-acting formulation of propranolol, a beta-blocker used to treat high blood pressure, angina, and certain heart-related conditions[1].
Market Context
Pharmaceutical Market Trends
The pharmaceutical market, particularly the segment involving cardiovascular medications like Inderal XL, is influenced by several factors including regulatory changes, technological advancements, and shifts in consumer demand. The biopharma and biotech industries are experiencing significant growth, with the biopharma market projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].
Prescription Drug Price Transparency
Price transparency has become a critical issue in the pharmaceutical industry. Programs like the Oregon Drug Price Transparency Program highlight the variability in drug pricing and the factors influencing these prices. For instance, the median price increase for generic drugs was 19.9% in 2022, while brand-name drugs saw a median increase of 13.4%[2].
Pricing Factors
Regulatory Influences
Regulatory frameworks play a crucial role in drug pricing. Manufacturers must report price increases and new high-cost drugs to regulatory bodies. The Oregon Drug Price Transparency Program, for example, requires manufacturers to provide detailed information on price increases, which can include factors such as research and development costs, rebates, and co-pay assistance programs[2].
Supply Chain Dynamics
The pharmaceutical supply chain, including interactions between manufacturers, health insurers, pharmacy benefit managers (PBMs), and pharmacies, significantly impacts drug prices. PBMs, in particular, influence pricing through rebates and other financial negotiations[2].
Market Competition
The level of competition in the market also affects drug prices. New brand-name drugs, especially those with limited competition, tend to be more expensive. Generic versions, like Inderal XL, may see price fluctuations based on the number of generic competitors and market demand[4].
Historical Pricing Data
NDC 62559-0601
As of the latest available data, Inderal XL (NDC 62559-0601) has not been reported to have significant price increases or deletions from the market. However, the broader trend in generic drug pricing suggests that prices can fluctuate based on various market and regulatory factors[1].
Price Projections
Short-Term Projections
Given the current market trends, it is likely that the price of Inderal XL will remain relatively stable in the short term. However, any significant changes in the regulatory landscape or shifts in market competition could lead to price adjustments.
Long-Term Projections
In the long term, several factors could influence the price of Inderal XL:
- Regulatory Changes: Implementing upper payment limits or bulk purchasing models, as recommended by some state programs, could potentially reduce prices[2].
- Market Competition: Increased competition from other generic versions of propranolol could drive prices down.
- Technological Advancements: Innovations in drug development and manufacturing could lead to more efficient production processes, potentially reducing costs.
Key Takeaways
- Market Stability: Inderal XL is likely to maintain stable pricing in the short term due to its established market presence.
- Regulatory Impact: Changes in regulatory policies, especially those related to price transparency and bulk purchasing, could significantly impact future pricing.
- Market Dynamics: Competition from other generic drugs and technological advancements will continue to shape the pricing landscape.
FAQs
-
What is Inderal XL used for?
Inderal XL is used to treat high blood pressure, angina, and certain heart-related conditions.
-
Who manufactures Inderal XL?
Inderal XL is manufactured by ANI Pharmaceuticals, Inc.
-
What are the key factors influencing drug prices?
Key factors include regulatory changes, market competition, supply chain dynamics, and technological advancements.
-
How does the Oregon Drug Price Transparency Program affect drug pricing?
The program requires manufacturers to report price increases and provides transparency into the factors influencing these prices, which can help in policy-making to control costs.
-
What are the long-term price projections for Inderal XL?
Long-term prices could be influenced by regulatory changes, increased market competition, and technological advancements, potentially leading to more stable or reduced prices.
Sources
-
ANI Pharmaceuticals, Inc. - List of Drugs - NDC Labeler/Manufacturer
https://www.findacode.com/ndc/labelers/ANI_Pharmaceuticals,_Inc.--62559
-
Prescription Drug Price Transparency Results and Recommendations
https://dfr.oregon.gov/drugtransparency/Documents/Prescription-Drug-Price-Transparency-Annual-Report-2022.pdf
-
5 Predictions for the Biopharma and Biotech Industries in 2025
https://tfscro.com/resources/5-predictions-for-the-biopharma-and-biotech-industries-in-2025/
-
Prescription Drug Price Transparency Results and Recommendations (2019)
https://dfr.oregon.gov/drugtransparency/Documents/Prescription-Drug-Price-Transparency-Annual-Report-2019.pdf
-
Label: THYROID tablet - DailyMed
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9b517204-3d73-410f-aa86-741f29e51906
